Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2023-07-07 00:00:00 ET · period of report 2023-07-07 · accession 0000899243-23-017267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-07-07 | 2023-07-07 | SKIN | Miller Brian Christopher | 10% | J - Other | $0.00 | -3.21M | 33.36M | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-07 | J | D | 3,207,261 | $0.00 | 33,360,741 | I See Footnote | — | — | (F2) The reported securities are directly held by LCP Edge Holdco, LLC. Linden Capital III LLC is the general partner of Linden Manager III LP, which in turn is the general partner of both Linden Capital Partners III LP and Linden Capital Partners III-A LP, which are the controlling stockholders of LCP Edge Holdco, LLC. As the members of a limited partner committee of Linden Capital III LLC that has the power to vote or dispose of the shares directly held by LCP Edge Holdco, LLC, Brian Miller and Anthony Davis may be deemed to have shared voting and investment power over such shares. Each of the reporting persons disclaim beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein. |